HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

LY 329722

phospholipase A2 inhibitor

Also Known As:

LY329722

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acetates: 4994
      - LY 329722: 2
Lipids: 114793
- Fatty Acids: 27405
  - Volatile Fatty Acids: 3052
    - Acetates: 4994
      - LY 329722: 2
Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - LY 329722: 2

Experts

1.	Fukai, M: 2 articles (04/2001 - 02/2001)
2.	Furukawa, H: 2 articles (04/2001 - 02/2001)
3.	Jin, M B: 2 articles (04/2001 - 02/2001)
4.	Ogata, K: 2 articles (04/2001 - 02/2001)
5.	Shimamura, T: 2 articles (04/2001 - 02/2001)
6.	Suzuki, T: 2 articles (04/2001 - 02/2001)
7.	Taniguchi, M: 2 articles (04/2001 - 02/2001)
8.	Todo, S: 2 articles (04/2001 - 02/2001)
9.	Fujita, M: 1 article (04/2001)
10.	Ishikawa, H: 1 article (04/2001)

Related Diseases

1.	Reperfusion Injury 04/27/2001 - "Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722." 02/01/2001 - "Inhibition of type II phospholipase A(2) by LY329722 attenuates ischemia and reperfusion injury of canine livers."
2.	Ischemia 04/27/2001 - "LY329722 was administered to animals in group 2 (n=6) intravenously (0.2 mg x kg(-1) x hr(-1)) for 60 min before ischemia, and to animals in group 3 (n=6) for 60 min starting 15 min before reperfusion (0.2 mg x kg(-1) x hr(-1)). " 04/27/2001 - "Attenuation of ischemia and reperfusion injury of canine livers by inhibition of type II phospholipase A2 with LY329722." 02/01/2001 - "Inhibition of type II phospholipase A(2) by LY329722 attenuates ischemia and reperfusion injury of canine livers."

Related Drugs and Biologics

1.	Phospholipases A2 (Phospholipase A2)
2.	Phospholipases (Phospholipase)